Article

Consuming genomes: scientific and social innovation in direct-to-consumer genetic testing

2012-03-20

Abstract excerpt

Since 2006 companies in the US have started to offer direct-to-consumer (DTC) genetic testing for a variety of diseases and traits. Recently, the activities of 23andMe and Navigenics, the two leading providers of DTC genetic services, have come under the scrutiny of various regulators and institutions, including the Food and Drug Administration (FDA) and the House Committee on Energy and Commerce and, in 2008, the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4232e1dc-0753-5611-bffc-b88f5a8b4ab9
DOI: 10.1080/14636778.2012.662032

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Consuming genomes: scientific and social innovation in direct-to-consumer genetic testingDOI 10.1080/14636778.2012.662032Read

Direct‐to‐consumer genetic testing: Perspectives on its value in healthcareSemantic proximity Read

The regulation of direct-to-consumer genetic tests.Semantic proximity Read

Keeping data alive: talking DTC genetic testingSemantic proximity Read

An exploration of genetic health professionals' experience with direct-to-consumer genetic testing in their clinical practiceSemantic proximity Read

State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Semantic proximity Read

Direct-To-Consumer Genetic Testing: Where and How Does Genetic Counseling Fit?Semantic proximity Read

[The genome and the consumer].Semantic proximity Read

23andMe resumes giving consumers genetic health information: Company's tests for rare and common diseases aren't diagnostic.Semantic proximity Read

The dawn of consumer‐directed testingSemantic proximity Read

Statement of the ESHG on direct-to-consumer genetic testing for health-related purposesSemantic proximity Read

Science and regulation. Regulating direct-to-consumer personal genome testing.Semantic proximity Read

Direct‐to‐consumer genetic testing: good, bad or benign?Semantic proximity Read